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One of the periodontal pathogenic bacteria that can cause periodontitis and alveolar bone 
destruction is Aggregatibacter actinomycetemcomitans. An alveolar bone defect can be treated using a bone 
graft. Carbonated hydroxyapatite (CHA) is an alloplastic graft material. Alloplastic materials do not have 
vascularization, which will increase the risk of bacterial adhesion. Therefore, adding an antibacterial agent 
is needed to prevent bacterial adhesion, which will improve periodontal healing. Propolis is a natural 
ingredient that has broad-spectrum antibacterial activity and does not cause bacterial resistance. This study 
aimed to assess the antibacterial activity of carbonated hydroxyapatite after being incorporated with 
propolis against Aggregatibacter actinomycetemcomitans. Carbonated hydroxyapatite was embedded into 
four different concentrations of propolis solution (2.5%, 5%, 7.5%, and 10%). An antimicrobial assay 
against Aggregatibacter actinomycetemcomitans was done using the disc diffusion test method. The 
inhibition zone was measured to determine the antibacterial ability of the specimens. The inhibition zone 
was found on the carbonated hydroxyapatite incorporated with propolis at all concentrations. Carbonated 
hydroxyapatite incorporated with 10% propolis showed the largest inhibition zone. Data analysis using the 
Kruskal–Wallis test showed a significant difference between the groups tested (P <.05). In conclusion, 
carbonated hydroxyapatite incorporated with propolis has antibacterial activity against Aggregatibacter 
actinomycetemcomitans 
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INTRODUCTION  
One of the periodontal pathogenic bacteria 
that can cause periodontitis and alveolar                
bone destruction is Aggregatibacter 
actinomycetemcomitans. An alveolar bone defect 
can be treated using a bone graft. Carbonated 
hydroxyapatite (CHA) is an alloplastic graft 
material. Alloplastic materials do not have 
vascularization, which will increase the risk of 
bacterial adhesion. Therefore, adding an 
antibacterial agent is needed to prevent bacterial 
adhesion, which will improve periodontal healing. 
Propolis is a natural ingredient that has broad-
spectrum antibacterial activity and does not cause 
bacterial resistance. This study aimed to assess the 
antibacterial activity of carbonated hydroxyapatite 
after being incorporated with propolis against 
Aggregatibacter actinomycetemcomitans. 
Carbonated hydroxyapatite was embedded into 
four different concentrations of propolis solution 
(2.5%, 5%, 7.5%, and 10%). An antimicrobial assay 
against Aggregatibacter actinomycetemcomitans 
was  done  using  the  disc   diffusion  test   method.      
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The inhibition zone was measured to determine 
the antibacterial     ability    of     the    specimens.             
The inhibition zone was found on the carbonated 
hydroxyapatite incorporated with propolis at all 
concentrations. Carbonated hydroxyapatite 
incorporated with 10% propolis showed the 
largest inhibition zone. Data analysis using the 
Kruskal–Wallis test showed a significant difference 
between the groups tested (P <.05). In conclusion, 
carbonated hydroxyapatite incorporated with 





Preparation of carbonated hydroxyapatite 
incorporated with propolis 
The carbonated hydroxyapatite used in this 
study was 10 mg Gama-CHA (Yogyakarta, 
Indonesia). The propolis solution was made using 
pure propolis (Propolis Brazilian® - Minas Gerais, 
Brazil) and sterile aquabidest, using the gradual 
dilution technique. The dilution was carried out 
until the propolis concentrations of 2.5%, 5%, 
7.5%, and 10% were obtained. The carbonated 
hydroxyapatite was then embedded into each 
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concentration of propolis solution for 24 h at room 
temperature. After 24 h, the specimens were then 
put into an incubator for another 24 h.                            






(ATCC 43718) were obtained from the laboratory 
of microbiology Dentistry Faculty Universitas 
Airlangga, Surabaya. The bacteria were cultured in 
brain heart infusion broth media and then 
incubated for 24 h. The bacterial suspension 
turbidity was compared with the 0.5 McFarland 
standard, which equals 1.5 × 108 colony forming 
units (CFU mL–1). A petri dish was prepared using 
nutrient agar. Then the surface was inoculated 
with bacteria using a sterile swab. 
The antimicrobial assay was done using the 
disc diffusion test and replicated five times. 
Specimens were put on the agar surface, and the 
inhibition zone was measured using a caliper after 
24 h. The carbonated hydroxyapatite that was not 




The data obtained from the antimicrobial 
assay  were  analyzed  with the Kruskal–Wallis test  
and continued with the least significant difference 
(LSD) posthoc test. The significance value was set 
at P < .05. 
 
RESULTS AND DISCUSSION 
There are several methods to test the 
antimicrobial ability of a material, such as the 
broth dilution test, antimicrobial gradient method, 
disc diffusion test, and automated instrument 
systems (Jorgensen & Ferraro, 2009).                           
The antimicrobial assay used in this study was the 
disc diffusion test. An antimicrobial assay for 
carbonated hydroxyapatite incorporated with 
propolis against A. actinomycetemcomitans was 
done in vitro. 
Figure 1 shows the inhibition zone on 
carbonated hydroxyapatite incorporated with four 
different concentrations of propolis. The mean 
diameter of the inhibition zone at a concentration 
of 10%, 7.5%, 5%, and 2.5% are 12.7 mm, 10.58 
mm, 8.9 mm, and 8 mm, respectively.  
The carbonated hydroxyapatite specimen 
that was not embedded in propolis had no 
inhibition zone, as seen in Figure 2. The mean value 
and standard deviation of each inhibition zone are 
shown in Table I. The diagram for the mean value 
of the inhibition zone in all tested groups is shown 
in Figure 3. 
The statistical analysis using the Kruskal–
Wallis test showed a significant difference (P <.05) 
 
Figure 1. Antimicrobial assay of carbonated hydroxyapatite incorporated with propolis at different 
concentrations against A. actinomycetemcomitans. 
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between all tested groups. A LSD posthoc test 
showed that there was a significant mean 
difference from each of the tested groups. 
The data showed that carbonated 
hydroxyapatite incorporated with 10% propolis 
had the highest antibacterial ability. The diameter 
of the inhibition zone showed that there was a 
positive correlation between the concentration of 
propolis used in the incorporation specimen and 
its antibacterial activity. 
As a natural ingredient, propolis is proven to 
have antimicrobial ability without causing 
bacterial resistance or eliminating oral microflora 
(Ghasemi et al., 2017). The antimicrobial property 
of propolis is mainly contributed by its flavonoid 
compound (Przybyłek and Karpinski, 2019).  
 
Figure II. Antimicrobial assay of carbonated hydroxyapatite against A. actinomycetemcomitans. 
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Besides flavonoids, phenolic acids and esters 
also play an essential role in propolis’s 
antimicrobial activity. Due to its sophisticated, 
active ingredients, the antimicrobial property of 
propolis may result from a synergistic effect 
between the compounds (Grenho et al., 2015). A 
previous study demonstrated that propolis could 
suppress the virulence factors of bacteria. The 
virulence factors that were suppressed in that 
study were lipase and coagulase enzymes. Besides 
suppressing these virulence factors, the same 
study proved that propolis was also capable of 
inhibiting the formation of biofilm by bacteria 
(Bueno-Silva et al., 2013). 
Virulence factors are metabolites of bacteria 
that are crucial for its survival while inside the host 
environment (How et al., 2016). Lipase is one of the 
virulence factors that are capable of converting 
host tissue into nutrients needed for its growth 
(Akca et al., 2016). In contrast, coagulase is an 
enzyme secreted by bacteria as its defense 
mechanism against the immune system of the host 
(McAdow et al., 2012). Biofilm formation is 
important for bacterial growth because once it is 
formed, bacteria are protected from the process of 
phagocytosis (Grenho et al., 2015). 
Several active ingredients of propolis, such 
as caffeic acid, benzoic acid, and cinnamic acid, act 
on the cell membrane or cell wall and result in the 
structural    and    functional    damage   of    bacteria 
(Przybyłek and Karpinski, 2019). Other 
mechanisms that might contribute to the 
antibacterial property of propolis are the 
disintegration of the bacterial cytoplasm, 
cytoplasmic membrane and cell wall, partial 
bacteriolysis, and inhibition of bacterial protein 
synthesis (Akca et al., 2016). 
In this study, carbonated hydroxyapatite 
that was embedded in the propolis solution 
showed a significant antibacterial effect against A. 
actinomycetemcomitans. The antibacterial effect is 
represented by the inhibition zone found during 
the experiment. The inhibition zone was             
shown   to   occur   in  a   dose-dependent   manner. 
 
This phenomenon suggests that embedding 
carbonated hydroxyapatite into propolis allowed 
the absorption of its active ingredients and showed 
an antibacterial effect. 
The results of this study are similar to the 
previous study that investigated the antibacterial 
effect of nano-hydroxyapatite that was embedded 
in propolis extract. The study proved that 
embedded nano-hydroxyapatite had an 
antibacterial effect against S. aureus, both in the 
planktonic and sessile state, through the formation 
of biofilm (Grenho et al., 2015). Unembedded 
nano-hydroxyapatite did not have this ability, 
similar to the findings in this current study. 
 
CONCLUSION 
This study proved that carbonated 
hydroxyapatite has antibacterial activity after the 
incorporation of propolis. The antibacterial 
property possessed by the incorporated specimen 
was directly proportional to the propolis 
concentration used in the embedding process. 
However, additional studies are still needed to 
investigate its antibacterial activity against other 
periodontal pathogenic bacteria and its effect on 
the formation of biofilm. 
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Table I. The mean value and standard deviation of the inhibition zone 
 
Group n Mean ± SD 
CHA 5 0 
CHA + 2.5% propolis 5 8 ± 0.15 
CHA + 5% propolis 5 8.9 ± 0.15 
CHA + 7.5% propolis 5 10.58 ± 0.13 
CHA + 10% propolis 5 12.7 ± 0.21 
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